Report Details

Service & Software

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Size, Share & Analysis By Product and Services (Kits and Enzymes, Libraries, gDNA Design & Vector Construction, Cell Line Engineering, Screening Services, Others), By Application (Biomedical, Industrial, Agricultural, and Others), By End-Use (Pharmaceutical and Biotechnology Companies, Academics and Government Research Institutes, CROs, Others), By Regional Outlook, Competitive Landscape And Forecast, 2032

By Type : Kits and Enzymes, Libraries, gDNA Design & Vector Construction, Cell Line Engineering, Screening Ser

By Application : Biomedical, Industrial, Agricultural, and Others

ID: XI645655 | Published: Jan 2024 | Pages: 210 | Format: Electronic (PDF) | Industry: Service & Software

Description

ToC

Companies

Speak with Analyst

CRISPR Technology Market Overview 2024:

The global CRISPR technology market size was USD 3 billion in 2023 and is expected to register a robust revenue CAGR of 15.8% over the forecast period. Rapid advancements in gene editing technology, rising prevalence of chronic and genetic diseases, and growing need for advanced gene editing tools are some key factors expected to drive global market growth during the forecast period.

Clustered Regulatory Interspaced Short Palindromic Repeats commonly called CRISPR is a family of DNA sequences found in the genomes of prokaryotic organisms like archaea and bacteria. CRISPR technology is a revolutionary technology used for gene editing and genetic engineering that allows scientists and experts to precisely modify DNA within organisms, including humans. The process typically consists of components such as CRISPR arrays that contain short, partially palindromic repeats of base sequence, Cas9, a protein that acts as a molecular pair of scissors and helps in precise cutting of DNA and gRNA, a synthetic RNA that guides Cas9 protein to this precise location.

CRISPR technology is rapidly gaining popularity and is steadily being used in areas such as gene therapy, agricultural applications, biomedical research, drug development, and livestock improvement. Many researchers and policymakers are working on expanding the applications of CRISPR technology and establishing guidelines and regulations to ensure its ethical and safe applications.

However, the costs associated with CRISPR development, research, and commercialization are quite high and many small to medium-scale institutes and companies may not be able to access the advanced tools due to limited budgets and infrastructure.

Key Takeaways:

Rising Investments in R&D Activities and Growing Demand for Personalized Medicine:

The rising prevalence of various genetic disorders has resulted in rising need for accurate and effective gene-editing tools to develop therapeutic interventions. This has encouraged companies and manufacturers in the pharmaceutical and biotechnology sectors to invest in R&D activities and develop innovative products and consumables. In addition, many companies are collaborating with other firms and academic institutions, contributing to the expansion of CRISPR research and its application across various fields. Other factors such as

Ethical and Regulatory Concerns and Competition from Other Gene Editing Technologies:

Though CRISPR technology is rapidly booming and rigorously being worked on, few factors such as stringent regulatory and ethical concerns, limited understanding of genomic functions, and competition from other gene editing technologies are expected to hamper the overall market growth to a certain extent during the forecast period.

Market Opportunities:

CRISPR technology is still in its experimental phase, but it has the potential to completely revolutionize the life science and healthcare fields and possess a significant opportunity to address various genetic disorders such as cystic fibrosis, muscular dystrophy and sickle cell anemia. Manufacturers and companies in the market are constantly striving to develop advanced tools and technologies to explore the applications of CRISPR technology across various sectors.

Products and Services Outlook:

Based on products and services, the global market is segmented into kits and enzymes, libraries, gDNA design & vector construction, cell line engineering, screening services, and others. Among these, the kits and enzymes segment is expected to account for largest revenue share during the forecast period. Factors such as ongoing research on CRISPR technology, high usage of various types of kits and enzymes in academic and research settings to conduct CRISPR experiments, and rising investments in developing more advanced kits and enzymes are expected to drive segment revenue growth during the forecast period.

Application Outlook:

The global market is segmented into pharmaceutical and biotechnology companies, academics and government research institutes, CROs, and others based on applications. The pharmaceutical and biotechnology companies segment is expected to register robust revenue CAGR over the forecast period owing to increasing prevalence of genetic diseases, growing need for advanced drugs and therapeutics, and rising number of pharmaceutical and biotechnology companies using CRISPR technology to identify and validate drug targets and perform functional genomics studies.

Regional Outlook:

North America is expected to account for largest revenue share during the forecast period owing to factors such as rapid advancements in gene editing technologies, growing need for advanced gene editing tools, rising prevalence of genetic disorders, and presence of advanced healthcare and research infrastructure and tools. In addition, presence of leading companies, growing demand for personalized medicine and synthetic biology, increasing collaborations and partnerships, and rising investments in R&D activities are expected to drive North America market growth during the forecast period.

Report Coverage:  

Report Details  Outcome
 Base Year for Estimation  2023
 Historical Data  2018-2022
 Forecast Period  2024-2032
 Segments Covered:   Products and Services, Application, End-Use and Region
 By Products and Services  Kits and Enzymes, Libraries, gDNA Design & Vector Construction, Cell Line Engineering, Screening Services, Others
 By Application  Biomedical, Industrial, Agricultural, and Others
 By End Use  Pharmaceutical and Biotechnology Companies, Academics and Government Research Institutes, CROs, Others
 Regional Scope  North America, Europe, Asia Pacific, Latin America, Middle East and Africa
 Country Scope  United States, Canada, Germany, France, UK, Italy, Russia, China, Japan, South Korea, Southeast Asia, India, Mexico, Brazil, Saudi Arabia, UAE, Turkey
 Qualitative Info  •Value Chain Analysis
 •Pricing Analysis
 •Regional Outlook
 •Market Trends
 •Market Share Analysis
 •Competition Analysis
 •Technological Advancements
 Key Players  Merck KGaA, Thermo Fisher Scientific, Origene Technologies, Inc., New England Biolabs, GenScript, GeneCopoeia, Inc., Cellecta, Inc., Agilent Technologies, Inc., PerkinElmer, Inc. (Horizon Discovery Ltd.), and Danaher Corporation (Integrated DNA Technologies)
 Customization Scope  10 Hours of Free Customization and Expert Consultation


Competitive Landscape:

The global CRISPR Technology market is extremely competitive, comprising several regional and global level key players. Leading key players are focused on adopting various strategic alliances like mergers and acquisitions, partnerships, joint ventures, collaborations, and product launches to maintain their global position and enhance their product offerings. They are also focused on innovation, and scalability, and are adapting to evolving technology trends and consumer needs.

Some Leading Market Companies Listed in the Report:

  • Merck KGaA
  • Thermo Fisher Scientific
  • Origene Technologies, Inc.
  • New England Biolabs
  • GenScript
  • GeneCopoeia, Inc.
  • Cellecta, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc. (Horizon Discovery Ltd.)
  • Danaher Corporation (Integrated DNA Technologies)

CRISPR Technology Industry Recent Developments:

  • In October 2023, bit, bio, a leading company coding human cells for novel cures, announced the launch of CRISPR-Ready ioGlutamatergic Neurons, the first-in-class stem-cell-derived human neurons containing Cas9 nuclease for gene knockouts.
  • In February 2023, Vertex Therapeutics launched plans for 1st CRISPR-based gene-editing therapy.
  • In June 2021, QIAGEN announced the launch of QIAprep&amp CRISPR kit and Q-Primer solutions for rapid and simplified analysis of gene-editing experiments.

The global CRISPR technology market has been segmented based on product & services, application, end use, and region:

By Product & Services:

  • Kits and Enzymes
  • Libraries
  • gDNA Design & Vector Construction
  • Cell Line Engineering
  • Screening Services
  • Others

By Application:

  • Biomedical
  • Industrial
  • Agricultural
  • Others

By End Use:

  • Pharmaceutical and Biotechnology Companies
  • Academics and Government Research Institutes
  • CROs
  • Others

By Region:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

FAQ

The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology market research report includes specific segments by region (country), i.e. North America, Europe, Asia Pacific, South America, Middle East and Africa

The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology market report provides global companies with an opportunity to enter new markets, invest in new sectors, analyze consumer reactions, investigate global competition, and ultimately make smart investments.

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology report covers the latest market developments in terms of acquisitions, growth strategies, joint ventures and collaborations, new product launches, and more on industry.

We can provide customization on reports prior to the sale. If you need customization we request you to provide specific details on customization prior to the dispatch. This is because we move fast with your queries as it requires a lot of diligence. There will be additional charges for customization once the report is dispatched to you and will be treated as post-sales query.

Requesting a Sample copy of the report from Xcellent Insights is hassle-free! You can either request it from the report page or call our sales Executive at US: +1 408 627 7717 /UK: +44 208 638 6439 and share/discuss your requirements. Our Team will share the sample copy of the report with you within 12 Working Hours / Shortly.

Ordering a report from Xcellent Insights is hassle-free! You can select a licence type that suits your requirement and proceed to checkout. It will redirect you to the payment gateway with a list of payment options. Be rest assured that we do not store the payment details. Once we receive the payment, a confirmation email will be sent on your registered mail id with details on the report delivery timeline. You can also get your order placed through our business development executives and they will guide you thoroughly.

  • You should buy this report from Xcellent Insights for a better clarity on market scenarios.
  • The market report has been prepared using a pragmatic approach to suit your needs.
  • We have an extensive library of reports that can help you understand the market landscape and make informed decisions about your business.
  • Additionally, the reports are written by experienced analysts who have a deep understanding of the market and the latest trends.
  • Besides, customization is a value-added service if you decide to opt.

Chapter 1. Methodology and Scope

1.1. Methodology Segmentation & Scope
1.2. Information Procurement
1.2.1. Purchased database
1.2.2. Secondary Sources
1.2.3. Third-party Perspectives
1.2.4. Primary research
1.3. Information Analysis
1.3.1. Data Analysis Models
1.4. Market Formulation & Data Visualization
1.5. Research Scope & Assumptions

Chapter 2. Executive Summary

2.1. CRISPR Technology Market- Industry Snapshot, 2018 - 2032

Chapter 3. CRISPR Technology Market Variables, Trends & Scope

3.1. Market Size and Growth Prospects, 2024-2032
3.2. Industry Value Chain Analysis
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint/Challenge Analysis
3.3.3. Market Opportunity Analysis
3.4. Penetration & Growth Prospect Mapping
3.5. Business Environment Analysis Tools
3.5.1. Industry Analysis - Porter's Five Forces Analysis
3.5.2. PEST Analysis
3.5.3. COVID-19 Impact Analysis

Chapter 4. CRISPR Technology Market Type Outlook 2024-2032 (USD Million)

Chapter 5. CRISPR Technology Market Application Outlook 2024-2032(USD Million)

Chapter 6: Coronavirus Diseases (COVID-19) Impact:

6.1. Introduction

6.2 Current and Future Impact Analysis

6.3 Economic Impact Analysis

6.4 Investment Scenario

Chapter 7. North America CRISPR Technology Market Share by Region, 2024 & 2032 (USD Million)

7.1. Market Estimates and Forecast 2024 - 2032 (USD Million)
7.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
7.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)
7.4.1. U.S.
7.4.1.1. Market Estimates and Forecast 2024-2032 (USD Million)
7.4.1.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
7.4.1.3 Market Estimates and Forecast by Application, 2024-2032 (USD Million)

7. 4.2. Canada
7. 4.2.1. Market Estimates and Forecast 2024-2032 (USD Million)
7. 4.2.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
7. 4.2.3 Market Estimates and Forecast by Application, 2024-2032 (USD Million)

Chapter 8. Europe CRISPR Technology Market Share by Region, 2024 & 2032 (USD Million)
 
8.1. Market Estimates and Forecast 2024 - 2032 (USD Million)
8.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
8.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)

8.4.1. Germany
8.4.1.1. Market Estimates and Forecast 2024-2032 (USD Million)
8.4.1.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
8.4.1.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)
8.4.2. France
8.4.2.1. Market Estimates and Forecast 2024-2032 (USD Million)
8.4.2.3. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
8.4.2.3. Market Estimates and Forecast by Application 2024-2032 (USD Million)
8.4.3.  UK
8.4.3.1. Market Estimates and Forecast 2024-2032 (USD Million)
8.4.3.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
8.2.3.3. Market Estimates and Forecast by Application 2024-2032 (USD Million)
8.4.4.  Italy
8.4.4.1. Market Estimates and Forecast 2024-2032 (USD Million)
8.4.4.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
8.4.4.3. Market Estimates and Forecast by Application 2024-2032 (USD Million)
8.4.5.  Russia
8.4.5.1. Market Estimates and Forecast 2024-2032 (USD Million)
8.4.5.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
8.4.5.3. Market Estimates and Forecast by Application 2024-2032 (USD Million)
8.4.6.  Nordic Countries
8.4.6.1. Market Estimates and Forecast 2024-2032 (USD Million)
8.4.6.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
8.4.6.3. Market Estimates and Forecast by Application 2024-2032 (USD Million)
8.4.7. Rest of Europe
8.4.7.1. Market Estimates and Forecast 2024-2032 (USD Million)
8.4.7.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
8.4.7.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)

Chapter 9. Asia Pacific CRISPR Technology Market Share by Region, 2024 & 2032 (USD Million)

9.1. Market Estimates and Forecast 2024 - 2032 (USD Million)
9.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
9.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)

9.4.1. China
9.4.1.1. Market Estimates and Forecast 2024-2032 (USD Million)
9.4.1.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
9.4.1.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)
9.4.2. Japan
9.4.2.1. Market Estimates and Forecast 2024-2032 (USD Million)
9.4.2.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
9.4.2.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)
9.4.3.  South Korea
9.4.3.1. Market Estimates and Forecast 2024-2032 (USD Million)
9.4.3.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
9.4.3.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)
9.4.4.  India
9.4.4.1. Market Estimates and Forecast 2024-2032 (USD Million)
9.4.4.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
9.4.4.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)
9.4.5.  Australia

9.4.5.1. Market Estimates and Forecast 2024-2032 (USD Million)
9.4.5.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
9.4.5.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)
9.4.6. Rest of Asia Pacific
9.4.6.1. Market Estimates and Forecast 2024-2032 (USD Million)
9.4.6.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
9.4.6.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)

Chapter 10. Latin America CRISPR Technology Market Share by Region, 2024 & 2032 (USD Million)

10.1. Market Estimates and Forecast 2024 - 2032 (USD Million)
10.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
10.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)

10.4.1. Mexico
10.4.1.1. Market Estimates and Forecast 2024-2032 (USD Million)
10.4.1.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
10.4.1.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)
10.4.2. Brazil
10.4.2.1. Market Estimates and Forecast 2024-2032 (USD Million)
10.4.2.2 Market Estimates and Forecast by Type, 2024-2032 (USD Million)
10.4.2.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)
10.4.3 Rest of Latin America
10.4.3.1 Market Estimates and Forecast 2024-2032 (USD Million)
10.4.3.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
10.4.3.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)

Chapter 11. Middle East and Africa CRISPR Technology Market Share by Region, 2024 & 2032 (USD Million)

11.1. Market Estimates and Forecast 2024 - 2032 (USD Million)
11.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
11.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million

11.4.1 Turkey
11.4.1.1 Market Estimates and Forecast 2024-2032 (USD Million)
11.4.4.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
11.4.4.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)
11.4.2.  Saudi Arabia
11.4.2.1. Market Estimates and Forecast 2024-2032 (USD Million)
11.4.2.2 Market Estimates and Forecast by Type, 2024-2032 (USD Million)
11.4.2.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)
11.4.3 UAE
11.4.3.1. Market Estimates and Forecast 2024-2032 (USD Million)
11.4.3.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
11.4.4.1. Market Estimates and Forecast by Application, 2024-2032 (USD Million)
11.4.5.  Rest of MEA
11.4.5.1. Market Estimates and Forecast 2024-2032 (USD Million)
11.4.5.2. Market Estimates and Forecast by Type, 2024-2032 (USD Million)
11.4.5.3. Market Estimates and Forecast by Application, 2024-2032 (USD Million)

Chapter 12 CRISPR Technology Market Competitive Landscape

  • Merck KGaA
  • Thermo Fisher Scientific
  • Origene Technologies, Inc.
  • New England Biolabs
  • GenScript
  • GeneCopoeia, Inc.
  • Cellecta, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc. (Horizon Discovery Ltd.)
  • Danaher Corporation (Integrated DNA Technologies)

Table & Figure

  • Merck KGaA
  • Thermo Fisher Scientific
  • Origene Technologies, Inc.
  • New England Biolabs
  • GenScript
  • GeneCopoeia, Inc.
  • Cellecta, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc. (Horizon Discovery Ltd.)
  • Danaher Corporation (Integrated DNA Technologies)

Speak With Analyst

Request Free PDF Sample
Pre-Order Enquiry
Check Today's Discount

Why Choose Us

  • Extensive Library of Reports.
  • Identify the clients' needs.
  • Pragmatic Research Approach.
  • Clarity on Market Scenarios.
  • Tailor-Made Solutions.
  • Expert Analysts Team.
  • Competitive and Fair Prices.

Clientele